Complex Karyotype and TP53 Alterations in AML and MDS

Hemato · Published 2026-08-03 · DOI 10.3390/hemato7030025

Free full text

Authors (1)

Ugo Testa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Testa, U. (2026). Complex Karyotype and TP53 Alterations in AML and MDS. Hemato. https://doi.org/10.3390/hemato7030025

Related articles

• Cytogenetics and genomics of acute myeloid leukemia · Best Practice and Research: Clinical Haematology · 2023 · Cites or is cited by this article
• High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China · Annals of Hematology · 2024 · Cites or is cited by this article
• Evolution to complex karyotype disease in mono-allelic TP53-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study · Haematologica · 2026 · Cites or is cited by this article
• Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics · Blood Neoplasia · 2026 · Cites or is cited by this article
• Flow Cytometry Immunophenotyping in Hematology Clinical Practice: Panacea or a Diagnostic Tool? Conclusions from a Case Report · Hemato · 2026 · Same journal
• Genome-Wide CRISPR-Cas9 Knockout Screening Identifies NUDCD2 Depletion as Sensitizer for Bortezomib, Carfilzomib and Ixazomib in Multiple Myeloma · Hemato · 2025 · Same journal
• Persistent Remission of Angioimmunoblastic T-Cell Lymphoma and Associated Immune-Mediated Thrombotic Thrombocytopenic Purpura After Multimodal Therapy: A Case Report · Hemato · 2026 · Same journal
• Comparative Analysis of Erythrocyte Morphology in Hematological Malignancies and Anemia · Hemato · 2026 · Same journal
• Primary Small Bowel MALT Lymphoma with Concurrent Pulmonary Dissemination: A Case Report · Hemato · 2026 · Same journal
• Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia · Hemato · 2026 · Same journal